Carmell Therapeutics plans to acquire Arizona biotech firm for $65M

Carmell Therapeutics Corp. said it plans to have Axolotl Biologix operate as a wholly-owned subsidiary of Carmell should the deal meet regulatory approvals and other conditions.

Atlanta jazz venue Churchill Grounds to reopen

KCK’s Spicin Foods whips up custom barbecue sauce for NFL Draft

Want a new starter home for less than $400,000 in metro Atlanta? Good luck.

Savoy sells at second-highest price in 2019

VF Corp.’s move to Denver could leave a huge hole on Alameda’s waterfront

Bank taking more space in its Clayton tower, as another firm exits

Hill Country Studios secures zoning, annexation approvals to keep massive project on schedule

Huntington cranks out Dayton business loan growth in Mullinger’s first year at helm

Carmell Therapeutics plans to acquire Arizona biotech firm for $65M

Previous Advent Therapeutics lands $3M NIH grant to advance therapy to benefit premature infants

Next Former CEO pleads guilty to lying to feds during $40M health care fraud investigation

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

BLT Enterprises names promotes Rob Solomon to president

Uber Eats, Nuro launching autonomous food deliveries in Houston, San Francisco Bay Area

Florida-based investor buys North Side shopping center

Bank of America donates $10M to Atrium Health for virtual health-care program in Charlotte schools

Region’s largest homebuilder, Fischer Homes, expands to Florida market with acquisition

List Extra: How we took the temperature of KC area’s hottest ZIP codes

MENU

FirstStar Group

More Stories

How Nashville’s new bank stacks up to its fellow startups

Previous Advent Therapeutics lands $3M NIH grant to advance therapy to benefit premature infants

Next Former CEO pleads guilty to lying to feds during $40M health care fraud investigation

firststargroup

Related Posts

Suggested Posts

MENU

FirstStar Group

More Stories